覆醛氧化淀粉治疗慢性肾衰

Clinical Efficacy of Oxyamyli Tectus Aldehydum in the Treatment of Patients with Chronic Renal Failure

本文报告10例慢性肾衰患者,于排除可逆因素并予以低蛋白饮食稳定1周后,给予口服覆醛氧化淀粉10～15g/日,2周。结果发现,治疗后10/10例临床症状有所改善,2/4例随大便量增多其氮排出量亦增加,但BuN、SCr及其他血生化指标无明显变化。本文提示,覆醛氧化淀粉可作为改善早期尿毒症患者临床症状的有效药物,但其疗效尚不能肯定。

After having been given a low protein diet for one week, 10 patients with CRF without reversible factors were treated with oxyamyli tectus aldehydum 10-15 g/day for two weeks. The clinical status of all of the patients improved. The nitrogen excretion in the stool was increased in 2/4 cases and stool volume also increased. No change was observed in BUN, CRE, or other serum chemistry. These results suggest that oxyamyli tectus aldehydum may be helpful in improving the clinical symptoms of patients with chronic renal failure (CRF). This conclusion, however, is tentative and not proven.